> The only thing holding this back is government bureaucracy and red tape.

Not really true. There have been clinical trials for Ibogaine over the years in the US and abroad. The United States isn’t the only country capable of running trials.

A big blocker for ibogaine is that it’s cardiotoxic. Multiple deaths have occurred within clinical trials for ibogaine. It’s really hard to justify and get approval for additional clinical trials for a drug that has caused deaths even in small trials.

There are analogs of ibogaine being studied, too. These are designed to lack the cardiac properties of ibogaine and would hold much more promise. There’s a real problem of mistrust with “artificial chemicals” that causes this to be ignored while ibogaine gets the attention. I suppose that’s to be expected with politicians driving research.